Photocure to Participate in Two Investor Conferences in April: DNB Small & Medium Enterprises and Needham Healthcare

On March March 29, 2022 Photocure ASA (OSE: PHO), The Bladder Cancer Company, reported that President and Chief Executive Officer, Dan Schneider and Chief Financial Officer, Erik Dahl will present corporate overviews and host 1-on-1 meetings with investors at the DNB Small & Medium Enterprises Conference on April 7, 2022, and the 21st Annual Needham Healthcare Conference being held virtually April 11-14, 2022 (Press release, PhotoCure, MAR 29, 2022, View Source;medium-enterprises-and-needham-healthcare-301512912.html [SID1234611146]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

For the Needham Healthcare Conference, Photocure’s presentation is scheduled to take place April 14th at 8:00am ET (2:00pm CET) and can be accessed via the following link: View Source

About the conferences:

Now in its 18th year, the DNB Small & Medium Enterprises Conference 2022 is a one-day conference that will include company presentations from various sectors. Before the pandemic, more than 500 investors, company representatives and other market participants from the Nordics, UK and Continental Europe attended the conference.
The 21st Annual Needham Virtual Healthcare Conference will feature leading public and private companies in the Biotechnology, Specialty Pharmaceuticals, Medical Technology, and Diagnostics sectors.